ADMA Biologics, Inc.ADMANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank57
3Y CAGR+9.6%
5Y CAGR-4.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+9.6%/yr
vs -2.0%/yr prior
5Y CAGR
-4.2%/yr
Recent acceleration
Acceleration
+11.7pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4.76M+162.6%
2024$1.81M-45.1%
2023$3.30M-8.7%
2022$3.61M-0.9%
2021$3.65M-38.3%
2020$5.91M+152.0%
2019$2.34M-40.3%
2018$3.93M-37.0%
2017$6.23M-19.0%
2016$7.69M-